These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 34890043)
1. The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women. Molina-Molina E; Furtado GE; Jones JG; Portincasa P; Vieira-Pedrosa A; Teixeira AM; Barros MP; Bachi ALL; Sardão VA Eur J Clin Invest; 2022 Mar; 52(3):e13731. PubMed ID: 34890043 [TBL] [Abstract][Full Text] [Related]
2. Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives. Venetsanaki V; Polyzos SA Curr Vasc Pharmacol; 2019; 17(6):546-555. PubMed ID: 29992886 [TBL] [Abstract][Full Text] [Related]
3. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. Robeva R; Mladenović D; Vesković M; Hrnčić D; Bjekić-Macut J; Stanojlović O; Livadas S; Yildiz BO; Macut D Maturitas; 2021 Sep; 151():22-30. PubMed ID: 34446275 [TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease. Rezende RE; Duarte SM; Stefano JT; Roschel H; Gualano B; de Sá Pinto AL; Vezozzo DC; Carrilho FJ; Oliveira CP Menopause; 2016 Aug; 23(8):876-83. PubMed ID: 27458060 [TBL] [Abstract][Full Text] [Related]
5. The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women. DiStefano JK Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375574 [TBL] [Abstract][Full Text] [Related]
6. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. Hamaguchi M; Kojima T; Ohbora A; Takeda N; Fukui M; Kato T World J Gastroenterol; 2012 Jan; 18(3):237-43. PubMed ID: 22294826 [TBL] [Abstract][Full Text] [Related]
7. Moderate to severe vasomotor symptoms are risk factors for non-alcoholic fatty liver disease in postmenopausal women. Ryu KJ; Park H; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T Maturitas; 2018 Nov; 117():22-28. PubMed ID: 30314557 [TBL] [Abstract][Full Text] [Related]
8. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH Liver Int; 2015 Mar; 35(3):944-52. PubMed ID: 24684289 [TBL] [Abstract][Full Text] [Related]
9. The influence of metabolic factors for nonalcoholic Fatty liver disease in women. Chung GE; Yim JY; Kim D; Lim SH; Yang JI; Kim YS; Yang SY; Kwak MS; Kim JS; Cho SH Biomed Res Int; 2015; 2015():131528. PubMed ID: 25973422 [TBL] [Abstract][Full Text] [Related]
11. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478 [TBL] [Abstract][Full Text] [Related]
12. Exercise against nonalcoholic fatty liver disease: Possible role and mechanism of lipophagy. Su P; Chen JG; Tang DH Life Sci; 2023 Aug; 327():121837. PubMed ID: 37301321 [TBL] [Abstract][Full Text] [Related]
13. Lack of association between early menopause and non-alcoholic fatty liver disease in postmenopausal women. Park SH; Park YE; Lee J; Choi JH; Heo NY; Park J; Kim TO; Moon YS; Kim HK; Jang HJ; Park HY; Jeong CH; Suk KT; Kim DJ Climacteric; 2020 Apr; 23(2):173-177. PubMed ID: 31538495 [No Abstract] [Full Text] [Related]
14. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Lonardo A Adv Ther; 2017 Jun; 34(6):1291-1326. PubMed ID: 28526997 [TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver-Adipose Tissue Crosstalk. Morán-Costoya A; Proenza AM; Gianotti M; Lladó I; Valle A Antioxid Redox Signal; 2021 Sep; 35(9):753-774. PubMed ID: 33736456 [No Abstract] [Full Text] [Related]
16. Fit mothers for a healthy future: Breaking the intergenerational cycle of non-alcoholic fatty liver disease with maternal exercise. Stevanović-Silva J; Beleza J; Coxito P; Costa RC; Ascensão A; Magalhães J Eur J Clin Invest; 2022 Mar; 52(3):e13596. PubMed ID: 34120338 [TBL] [Abstract][Full Text] [Related]
17. Serum Testosterone Level Within Normal Range Is Positively Associated with Nonalcoholic Fatty Liver Disease in Premenopausal but Not Postmenopausal Women. Park JM; Lee HS; Oh J; Lee YJ J Womens Health (Larchmt); 2019 Aug; 28(8):1077-1082. PubMed ID: 30653387 [No Abstract] [Full Text] [Related]
18. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. Ore A; Akinloye OA Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028 [TBL] [Abstract][Full Text] [Related]
19. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Moon SS; Lee YS; Kim SW Endocrine; 2012 Oct; 42(2):423-9. PubMed ID: 22407492 [TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women. Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]